February 2018

As a financial analyst, I provide post-award research administration for Drs. Arkin, Altschuler, Huang, Miller, Renslo, Sakanari, Shu, Wang and Wu, including assisting with the development of proposals and budgets, ensuring agency and campus policy compliance; handling project set-up, financial management of funds, interim budget reports and expenditure projections; performing cost transfers; coordinating project close-out and the preparation of final reports.

My primary interest is identification of genetic determinants of drug response through modern methods aimed at addressing pharmacogenomics research and translating that information into new diagnostics and treatment strategies at point-of-care.

I work with the dean as well as the vice dean of academic affairs to develop new avenues for incentivizing faculty success and retention.

During my research career, I applied biophysics, chemistry, and immunology to understand and devise better ways to deliver drugs, proteins, and nucleic acids to treat cancer and infectious diseases.

I co-lead the School’s plans for developing graduate education programs in the computational and experimental sciences along with Rada Savic, PhD. These programs are geared toward giving the School’s PharmD students greater career opportunities throughout biomedicine.

As a faculty member in the Department of Pharmaceutical Chemistry, I develop new methods for drug discovery, adopting two strategies to do so. On the one hand, we reduce biology to its molecular components, and seek to change how these fit together using synthetic molecules we design. On the other hand, we investigate how the biological molecules operate together, both in health and disease. Both processes involve intensive modeling and close collaboration between theory and experiment.